Warning letter
Columbine Specialty Products Inc. [ARCHIVED]: warning letter of May 27, 2011
FDA warning letter 167752 · Denver District Office
Key facts
| Reference number | 167752 |
|---|---|
| Company | Columbine Specialty Products Inc. [ARCHIVED] |
| Subject | CGMP For Manfacturing, Processing, Packing, Storage & Holding/Adulterated |
| Issue date | May 27, 2011 |
| Posted date | May 27, 2011 |
| Issuing office | Denver District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.5, 111, 111.70, 111.370, 111.30(e), 111.35(b)(6), 111.70(a), 111.70(b), 111.70(b)(1), 111.70(e), 111.75(a)(2)(ii), 111.95(b)(1) and 19 more |
| Inspection city | Denver |
| Inspection ZIP | 80216 |
| Inspection start date | Dec 2, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: